Side Effects to Monitor on Sprintec
Patients on Sprintec should primarily monitor for bleeding irregularities (breakthrough bleeding/spotting), blood pressure changes, mood symptoms (depression/anxiety), headaches/migraines, and signs of serious thromboembolic events.
Common and Expected Side Effects
Bleeding Pattern Changes
The most frequently encountered side effects are breakthrough bleeding and spotting, especially during the first three months of use 1. According to the FDA label, after six cycles:
- Spotting occurs in 4% of users
- Breakthrough bleeding in 3%
- Amenorrhea (no period) in 1% 1
These bleeding irregularities typically improve with continued use. If they persist beyond 3 months, patients should contact their provider to rule out pregnancy, infection, or other pathology 2.
Cardiovascular Effects
Blood pressure monitoring is essential as combined hormonal contraceptives containing ethinyl estradiol can cause hypertension 1. The FDA label notes that blood pressure increases are more likely in older users and with extended duration of use 1. However, it's worth noting that in two large clinical trials (N=633 and N=911), no statistically significant changes in mean blood pressure were observed with norgestimate/ethinyl estradiol specifically 1. Despite this, the 2023 Hypertension guidelines confirm that ethinyl estradiol at doses of 30-35 μg (the dose in Sprintec) can elevate blood pressure 3.
Key monitoring point: Check blood pressure at follow-up visits. If significant elevation occurs, discontinue the medication 1.
Neuropsychological Side Effects
Patients should watch for:
- Depression and anxiety: Recent FAERS data (2016-2020) showed that pills containing norgestimate had higher rates of reported depression and anxiety compared to reference pills 4
- Headaches and migraines: The onset or worsening of migraines requires immediate discontinuation 1. Norgestimate-containing pills showed increased migraine reports in adverse event databases 4
Dermatologic Effects
Acne may paradoxically worsen initially despite norgestimate's anti-androgenic properties. The 2016-2020 FAERS data showed higher acne rates with norgestimate pills 4, though the triphasic formulation is FDA-approved for acne treatment 5. This apparent contradiction likely reflects individual variation in response.
Other Common Side Effects
From large-scale studies (N=59,701), the following occurred at low frequencies 6:
- Nausea
- Weight changes (minimal effects noted)
- Breast tenderness
Importantly, a placebo-controlled trial showed that side effect rates with norgestimate/ethinyl estradiol did not differ significantly from placebo 7, suggesting excellent overall tolerability.
Serious Side Effects Requiring Immediate Medical Attention
Thromboembolic Events (CRITICAL)
Watch for signs of:
- Deep vein thrombosis: leg pain, swelling, warmth
- Pulmonary embolism: chest pain, shortness of breath
- Stroke: sudden severe headache, vision changes, weakness
- Myocardial infarction: chest pain radiating to arm/jaw
Important context: Norgestimate is associated with the lowest venous thromboembolism risk among combined oral contraceptives according to the European Medicines Agency 8, making it one of the safer options in this class.
Other Serious Complications
- Gallbladder disease: Right upper quadrant pain (though recent studies suggest minimal risk with modern low-dose formulations) 1
- Liver problems: Jaundice, severe abdominal pain
- Severe hypertension: Severe headache, vision changes
Metabolic Monitoring
Glucose Metabolism
For diabetic or prediabetic patients, monitor blood glucose levels. Clinical studies with norgestimate/ethinyl estradiol showed no clinically significant changes in fasting blood glucose over 24 cycles 1, which is reassuring.
Lipid Effects
The medication may affect lipid metabolism. Studies showed significant elevation in HDL cholesterol at 3 and 12 months with no change in total cholesterol 9, which is actually a favorable profile.
Clinical Pitfalls to Avoid
Don't dismiss early bleeding irregularities: Reassure patients this is normal in the first 3 months, but investigate if persistent 2
Don't ignore mood changes: While norgestimate has anti-androgenic properties that theoretically should help mood, real-world data shows increased depression/anxiety reports 4
Don't forget pregnancy testing: If two consecutive periods are missed, rule out pregnancy before continuing 1
Don't overlook contraindications: Women with history of hypertension, thromboembolic disease, or migraine with aura should use alternative contraception 1
When to Discontinue
Stop Sprintec immediately if the patient develops:
- New onset or worsening migraines with focal neurological symptoms
- Significant blood pressure elevation
- Signs of thromboembolism
- Jaundice or severe liver dysfunction
- Confirmed pregnancy 1
The patient should be offered counseling on alternative contraceptive methods and can initiate another method if desired 2.